AMERICA STEM CELL, INC. RECEIVES FDA CLEARANCE FOR ITS MULTI-CENTER NATIONWIDE TRIAL
San Antonio, TX SEPTEMBER 4, 2012. America Stem Cell, Inc. (ASC) announced today it has received clearance from FDA for its Phase I/IIa nationwide multi-center dual-umbilical cord transplantation study evaluating ASC-101 in in patients with hematologic malignancies and myelodysplastic syndrome.
ASC-101 is currently undergoing evaluation in a single-center study at The University of Texas MD Anderson Cancer. To date, 12 patients have been enrolled in the study with 9 patients evaluable. On the basis of data obtained in the single-center study, FDA has given approval to proceed with a […]